Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.
Virology. 2012 Oct 25;432(2):389-93. doi: 10.1016/j.virol.2012.06.018. Epub 2012 Jul 17.
We previously showed that a pandemic virus, A/Tennessee/560/09(H1N1), had the potential to adapt to human bronchial epithelial cells by the acquisition of hemagglutinin (HA) K154Q and polymerase acidic (PA) protein L295P mutations that conferred a more virulent phenotype. To better elucidate the role of each mutations, we generated recombinant viruses carrying single mutations or both mutations concurrently. The replication of all mutant viruses was significantly higher than that of the wild-type A/Tennessee/560/09 virus in human cells. The HA K154Q mutation reduced the receptor binding affinity of A/Tennessee/560/09 virus to 6-Su-6'SLN and biantennary 6'SLN receptors. In ferrets, H1N1 virus with HA K154Q and PA L295P mutations exhibited significantly higher titers in the upper respiratory tract compared to all other viruses 6 days post-infection. Our results suggest that both single mutations HA K154Q and PA L295P are necessary for delayed virus clearance of A/Tennessee/560/09(H1N1) influenza virus in a ferret animal model.
我们之前曾表明,通过获得血凝素(HA)K154Q 和聚合酶酸性(PA)蛋白 L295P 突变,大流行病毒 A/Tennessee/560/09(H1N1)有潜力适应人类支气管上皮细胞,从而产生更具毒性的表型。为了更好地阐明每个突变的作用,我们生成了携带单个突变或同时携带两个突变的重组病毒。所有突变病毒在人类细胞中的复制能力均明显高于野生型 A/Tennessee/560/09 病毒。HA K154Q 突变降低了 A/Tennessee/560/09 病毒对 6-Su-6'SLN 和双天线 6'SLN 受体的受体结合亲和力。在雪貂中,具有 HA K154Q 和 PA L295P 突变的 H1N1 病毒在感染后 6 天在上呼吸道中的滴度明显高于所有其他病毒。我们的研究结果表明,HA K154Q 和 PA L295P 这两种单突变对于 A/Tennessee/560/09(H1N1)流感病毒在雪貂动物模型中延迟清除病毒都是必需的。